Swain will oversee greater integration across private equity capital raising, secondary operations and strategic advisory at a time of growing overlap between Triago’s expanding businesses.
The creation of the Triago Advisory Board further enriches Triago’s expertise and complements expansion that has seen team numbers rise 29 percent across all businesses, geographies and seniority levels in the past 12 months.
The target of the standalone deal – done outside of a traditional PE fund structure – is the Clean Technologies business of NYSE-listed materials group DuPont de Nemours, Inc.
Valerie Auffray joins as a Partner based out of the firm’s London office. Matt Swain and Victor Quiroga, based in New York, have been named Co-Heads of the Americas. The post, with cross-business responsibilities, is a newly created position.
Hired as Partner and head of the group’s Dubai office, Khuram Maqsood will lead Triago’s ongoing expansion in the Middle East across all activities - private equity fundraising, secondary sales of private equity fund stakes, and strategic advisory of all types for private equity managers and investors.
Nicolas de Nazelle's wide ranging views on COVID-19's challenges for PE in both the primary and secondary markets.
By Mathieu Drean (Guest column for Private Equity International). Mathieu is managing partner in charge of global secondaries at private equity fund advisory Triago. He closed his first secondary transactions in the late 90s using faxes and surrounded by boxes of Xeroxed financials.
The market for second hand private-equity interests is increasingly awash with debt. Data from private-equity adviser Triago shows how much secondary investors have leveraged their deals to enhance returns. Based on an analysis of 1,217 transactions since 2013, Triago estimated that debt accounted for23% of the money spent on private-equity secondaries deals last year, up from 19% in 2016 and just 4% in 2013.
Private equity firm Archimed, which was founded by the former healthcare division leaders at UK buyout house 3i, has closed its second fund at €315m (£278m).After just four months of fundraising, Med II has exceeded its target by more than 25 per cent and is double the size of its predecessor.The firm, which currently owns UK-based occupational health business RehabWorks, will complete unleveraged growth investments and leveraged buyouts in the medtech, biopharma, care services and preventative healthcare sectors.
Few young private equity firms have created the kind of stir that Mayfair Equity partners has.